Regional Media

Clear 79°. Wind: SE 3 mph.
Loading advertisement…
Trending: A forced-labor crackdown or an end-run around Congress? Dissecting Trump’s new tariffs
HomeNewsNationalHealth ( Page 46)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Free speech issues raised as calls come for Pritzker to veto social media safety bill

(The Center Square) - Since the Illinois General Assembly passed a bill aiming to increase protections for children online, concerns have been raised by industry groups about the measure's constitutionality. ...
by

Pfizer CEO warns German investment at risk over drug pricing policies

By Maggie Fick, Bhanvi Satija and Patricia Weiss LONDON/FRANKFURT, June 10 (Reuters) - Pfizer is reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said in a letter to Chancellor Friedrich Merz, the latest drugmaker to react to government policy proposals ...
by

Older drug reprograms white blood cells, improves blood sugar in type 1 diabetes

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid June 10 (Reuters) - We also report on promising early data that could produce a better option for treating C. difficile-caused diarrhea, and the ...
by

Apotex Health shares jump in Toronto stock market debut

By Fergal Smith TORONTO, June 10 (Reuters) - Canadian health company Apotex Health rose about 17% above the initial public offering price at its Toronto market debut on Wednesday, bringing life back to a subdued market that had struggled to see new IPOs for years. ...
by

Organon wins US approval to widen use of arthritis biosimilar drug

June 10 (Reuters) - Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a life‑threatening immune reaction in some cancer patients and COVID-19 in patients needing breathing ...
by

US urges Europe to step up travel measures to prevent spread of Ebola from Africa

WASHINGTON (AP) - The Trump administration is telling European nations that they need to step up their travel restrictions for people coming to the continent from Ebola-hit countries in Africa, hinting that failure to do so may result in increased U.S. regulations on travel ...
Loading advertisement…
by

Canadian health firm Apotex prices IPO at top end, raising C$1.3 billion

June 9 (Reuters) - Canadian health company Apotex Health on Tuesday priced its upsized initial public offering at the top of the range at C$24 per share, raising gross proceeds of about C$1.3 billion ($931.90 million). The company said it sold 54.17 million common shares ...
by

Sanofi ends Phase 3 riliprubart trial after weak interim results

June 10 (Reuters) - Biopharmaceutical company Sanofi will stop a Phase 3 trial of its drug riliprubart for a rare neurological condition after an interim analysis of the study found it unlikely to provide sufficient efficacy. In the MOBILIZE study, the drug was being tested ...
by

Illinois Quick Hits: Raoul says office shorted about $10M

(The Center Square) - Illinois Attorney General Kwame Raoul says his office has been shorted about $10 million from its overall state budget appropriation in 2026. Raoul said during ...
by

Illinois Quick Hits: Mexican national sentenced for unlawful reentry

(The Center Square) - A Mexican national has been sentenced to 14 months in prison for unlawfully re-entering the United States after multiple deportations. U.S. government attorneys say Manuel ...
by

AlzeCure signs collaboration, out-licensing deal with Lilly for Alzheimer’s drug

June 9 (Reuters) - AlzeCure Pharma said on Tuesday it had entered a collaboration and out-licensing agreement with Eli Lilly for the global rights of an Alzheimer's treatment in a deal that could exceed $1 billion in total value. AlzeCure develops small-molecule drug candidates for ...
by

GSK boosts lung cancer portfolio with $10.6 billion Nuvalent takeover

June 9 (Reuters) - British drugmaker GSK on Tuesday agreed to acquire U.S.-listed cancer drug developer Nuvalent for $10.6 billion to boost its lung cancer portfolio. The all-cash deal values Nuvalent at approximately $124 per share, a 40% premium to its last closing price. GSK's CEO ...
First Previous424344454647484950Next Last